RYDAPT

RYDAPT was reported 1957 times

RYDAPT is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MYELOBLAST PERCENTAGE DECREASED 7 0.5833
1 MASTOCYTIC LEUKAEMIA 3 0.1579
2 LEUKAEMIC RETINOPATHY 1 0.1250
3 ADVANCED SYSTEMIC MASTOCYTOSIS 2 0.1111
4 OESOPHAGOGASTRODUODENOSCOPY ABNORMAL 3 0.1071
5 MYELOBLAST PRESENT 1 0.0714
6 SYSTEMIC MASTOCYTOSIS 21 0.0698
7 BLEPHARITIS ALLERGIC 2 0.0645
8 TRYPTASE DECREASED 3 0.0588
9 ABDOMINAL WALL WOUND 8 0.0519
10 LIVER SARCOIDOSIS 3 0.0448
11 ACUTE MYELOID LEUKAEMIA RECURRENT 93 0.0433
12 CONGENITAL APLASIA 11 0.0354
13 CERVIX OEDEMA 1 0.0323
14 NECROTISING GASTRITIS 1 0.0312
15 CATABOLIC STATE 2 0.0299
16 HEPATIC CANDIDIASIS 2 0.0294
17 HAEMORRHAGIC URTICARIA 1 0.0250
18 BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASIA 2 0.0247
19 ACUTE MOTOR-SENSORY AXONAL NEUROPATHY 5 0.0217
20 RIGHT VENTRICULAR EJECTION FRACTION DECREASED 1 0.0213
21 MINIMAL RESIDUAL DISEASE 9 0.0186
22 ACUTE MEGAKARYOCYTIC LEUKAEMIA 1 0.0182
23 MONOCLONAL B-CELL LYMPHOCYTOSIS 2 0.0175
24 SKIN LESION INFLAMMATION 2 0.0152
25 BLAST CELL COUNT DECREASED 1 0.0137
26 FIBROSARCOMA 1 0.0127
27 UTERINE LEIOMYOSARCOMA 1 0.0125
28 MUCOSAL PAIN 1 0.0119
29 INTENTIONAL MISUSE OF DRUG DELIVERY SYSTEM 1 0.0119
30 TRYPTASE INCREASED 8 0.0112
31 ENTEROBACTER SEPSIS 4 0.0108
32 CAPNOCYTOPHAGA INFECTION 1 0.0106
33 ORGAN TRANSPLANT 1 0.0102
34 SKIN TOXICITY 57 0.0101
35 SEVERE ACUTE RESPIRATORY SYNDROME 2 0.0091
36 BONE MARROW NECROSIS 2 0.0085
37 OLIGODENDROGLIOMA 1 0.0083
38 STENOTROPHOMONAS SEPSIS 1 0.0083
39 LIPASE DECREASED 1 0.0081
40 PHARYNGEAL ABSCESS 4 0.0080
41 ASPIRATION BONE MARROW 1 0.0075
42 GASTROINTESTINAL MUCOSAL EXFOLIATION 1 0.0075
43 NEUTROPENIC COLITIS 15 0.0072
44 FUSARIUM INFECTION 5 0.0071
45 CHLOROMA 3 0.0071
46 OROPHARYNGEAL OEDEMA 1 0.0069
47 LEUKAEMIA CUTIS 1 0.0065
48 INFECTIVE GLOSSITIS 1 0.0064
49 URAEMIC ENCEPHALOPATHY 2 0.0064
50 MYELOID LEUKAEMIA 3 0.0060
51 SOFT TISSUE INFLAMMATION 2 0.0059
52 ACUTE MYELOID LEUKAEMIA REFRACTORY 1 0.0058
53 BONE MARROW MYELOGRAM ABNORMAL 1 0.0057
54 CHRONIC LEUKAEMIA 1 0.0057
55 LONG QT SYNDROME 13 0.0054
56 GRANULOCYTOSIS 1 0.0051
57 MEGACOLON 8 0.0051
58 EXSANGUINATION 1 0.0050
59 LEUKAEMIA RECURRENT 8 0.0047
60 ANAL INFLAMMATION 3 0.0047
61 CEREBRAL MICROHAEMORRHAGE 2 0.0044
62 CENTRAL NERVOUS SYSTEM FUNGAL INFECTION 1 0.0043
63 MASTOCYTOSIS 2 0.0042
64 BONE MARROW TRANSPLANT 8 0.0042
65 DYSPLASIA 5 0.0042
66 BLAST CELLS PRESENT 2 0.0042
67 SPLENIC HAEMORRHAGE 2 0.0039
68 EYELID CYST 1 0.0039
69 GLOMERULONEPHRITIS MEMBRANOPROLIFERATIVE 2 0.0038
70 RESPIRATORY TRACT INFECTION FUNGAL 2 0.0038
71 BONE MARROW FAILURE 76 0.0037
72 PERIPHERAL PARALYSIS 1 0.0037
73 MALIGNANT NEOPLASM OF EYE 1 0.0035
74 AGITATED DEPRESSION 1 0.0035
75 TISSUE INFILTRATION 1 0.0034
76 HYPERLEUKOCYTOSIS 3 0.0034
77 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 3 0.0032
78 INSULIN-REQUIRING TYPE 2 DIABETES MELLITUS 1 0.0032
79 CELLULITE 1 0.0031
80 PACKAGING DESIGN ISSUE 1 0.0030
81 DRUG THERAPY 1 0.0029
82 MARROW HYPERPLASIA 2 0.0029
83 BONE MARROW OEDEMA 3 0.0029
84 LEUKAEMIA 27 0.0029
85 INFECTION IN AN IMMUNOCOMPROMISED HOST 2 0.0028
86 CORONARY ARTERY INSUFFICIENCY 1 0.0028
87 VENOUS PRESSURE JUGULAR INCREASED 1 0.0028
88 PNEUMONIA KLEBSIELLA 5 0.0027
89 BRONCHOPNEUMOPATHY 1 0.0027
90 BONE MARROW INFILTRATION 1 0.0026
91 EYE INFECTION FUNGAL 1 0.0026
92 PNEUMONIA FUNGAL 10 0.0025
93 STREPTOCOCCAL SEPSIS 3 0.0025
94 RED BLOOD CELL TRANSFUSION 1 0.0024
95 SYSTOLIC HYPERTENSION 1 0.0023
96 CYTOPENIA 28 0.0023
97 CEREBELLAR SYNDROME 5 0.0023
98 EPIDERMOLYSIS 1 0.0022
99 ECHOCARDIOGRAM ABNORMAL 3 0.0021
100 BIOPSY BONE MARROW 1 0.0021
101 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 3 0.0021
102 INTUSSUSCEPTION 2 0.0021
103 ESCHERICHIA SEPSIS 6 0.0021
104 ONCOLOGIC COMPLICATION 2 0.0021
105 NEOPLASM RECURRENCE 7 0.0021
106 WOUND SECRETION 8 0.0020
107 ENDOCARDITIS STAPHYLOCOCCAL 1 0.0020
108 HYPERSPLENISM 1 0.0020
109 ACUTE MYELOID LEUKAEMIA 31 0.0020
110 COMPLICATIONS OF TRANSPLANT SURGERY 1 0.0020
111 URINARY TRACT PAIN 1 0.0020
112 RIGHT ATRIAL DILATATION 1 0.0020
113 POST PROCEDURAL DIARRHOEA 1 0.0020
114 LEFT VENTRICULAR DILATATION 1 0.0020
115 INVASIVE LOBULAR BREAST CARCINOMA 1 0.0019
116 CYTOGENETIC ANALYSIS ABNORMAL 2 0.0019
117 EXECUTIVE DYSFUNCTION 1 0.0018
118 MANUFACTURING PRODUCT SHIPPING ISSUE 1 0.0018
119 LYMPHADENOPATHY 60 0.0017
120 ALVEOLAR PROTEINOSIS 1 0.0017
121 CAMPYLOBACTER GASTROENTERITIS 1 0.0017
122 ANAL ABSCESS 9 0.0017
123 PANCYTOPENIA 93 0.0017
124 ENTEROCOCCAL INFECTION 8 0.0017
125 OTITIS EXTERNA 2 0.0016
126 INTRA-ABDOMINAL HAEMATOMA 2 0.0016
127 REMISSION NOT ACHIEVED 1 0.0016
128 HEPATOBILIARY DISEASE 1 0.0016
129 MYOCARDITIS 18 0.0016
130 BLOOD BILIRUBIN ABNORMAL 2 0.0016
131 KLEBSIELLA TEST POSITIVE 1 0.0015
132 HYPERMAGNESAEMIA 1 0.0015
133 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 2 0.0015
134 CHRONIC MYELOMONOCYTIC LEUKAEMIA 1 0.0015
135 STENOTROPHOMONAS INFECTION 2 0.0015
136 KERATOACANTHOMA 1 0.0015
137 HYPERBILIRUBINAEMIA 15 0.0014
138 BRAIN CANCER METASTATIC 1 0.0014
139 PRODUCT EXPIRATION DATE ISSUE 2 0.0014
140 ELECTROCARDIOGRAM ST-T CHANGE 1 0.0014
141 FEBRILE BONE MARROW APLASIA 6 0.0014
142 ANAEMIA MACROCYTIC 3 0.0014
143 RETINAL HAEMORRHAGE 10 0.0014
144 ALANINE AMINOTRANSFERASE DECREASED 1 0.0014
145 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 13 0.0014
146 CARDIAC FIBRILLATION 2 0.0014
147 CLOSTRIDIUM TEST POSITIVE 3 0.0014
148 PRODUCT LOT NUMBER ISSUE 3 0.0014
149 EJECTION FRACTION DECREASED 21 0.0013
150 MYELOSUPPRESSION 48 0.0013
151 PULMONARY MYCOSIS 1 0.0013
152 ELECTROCARDIOGRAM REPOLARISATION ABNORMALITY 1 0.0013
153 MYOPERICARDITIS 1 0.0013
154 BLOOD FIBRINOGEN INCREASED 1 0.0013
155 SINUSITIS FUNGAL 1 0.0012
156 ENTEROCOCCAL SEPSIS 1 0.0012
157 SPLENIC RUPTURE 2 0.0012
158 STEM CELL TRANSPLANT 3 0.0012
159 OESOPHAGEAL RUPTURE 1 0.0012
160 FEBRILE NEUTROPENIA 78 0.0012
161 HEPATOSPLENOMEGALY 3 0.0012
162 TRANSFUSION REACTION 1 0.0011
163 LUNG INFILTRATION 10 0.0011
164 JUGULAR VEIN THROMBOSIS 2 0.0011
165 ABDOMINAL NEOPLASM 1 0.0011
166 GRAFT VERSUS HOST DISEASE 8 0.0011
167 NEUROPSYCHIATRIC SYMPTOMS 1 0.0011
168 PRODUCT OUTER PACKAGING ISSUE 1 0.0011
169 BLOOD PHOSPHORUS INCREASED 3 0.0011
170 HEPATIC CYTOLYSIS 14 0.0011
171 CHEMOTHERAPY 4 0.0011
172 BLOOD ALKALINE PHOSPHATASE DECREASED 1 0.0011
173 LIPOATROPHY 1 0.0011
174 BRONCHOPULMONARY ASPERGILLOSIS 8 0.0010
175 APLASIA 2 0.0010
176 SUBCUTANEOUS EMPHYSEMA 1 0.0010
177 COLON ADENOMA 1 0.0010
178 DEVICE RELATED SEPSIS 2 0.0010
179 HYPERURICAEMIA 4 0.0010
180 CACHEXIA 5 0.0010
181 BLAST CELL COUNT INCREASED 1 0.0010
182 THYROID HORMONES INCREASED 1 0.0010
183 OEDEMA MUCOSAL 1 0.0010
184 URINARY BLADDER HAEMORRHAGE 2 0.0009
185 EAR SWELLING 2 0.0009
186 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 2 0.0009
187 BACTERAEMIA 11 0.0009
188 SOMATIC SYMPTOM DISORDER 1 0.0009
189 STREPTOCOCCAL BACTERAEMIA 1 0.0009
190 ASPERGILLUS INFECTION 6 0.0009
191 GRAFT VERSUS HOST DISEASE IN SKIN 2 0.0009
192 KLEBSIELLA SEPSIS 1 0.0009
193 CYTOGENETIC ABNORMALITY 1 0.0009
194 BLOOD FIBRINOGEN DECREASED 1 0.0009
195 ACUTE GRAFT VERSUS HOST DISEASE 4 0.0009
196 ENTEROCOLITIS 5 0.0009
197 NEUROLOGICAL DECOMPENSATION 2 0.0009
198 MACROCYTOSIS 1 0.0009
199 PROCALCITONIN INCREASED 1 0.0009
200 ESCHERICHIA BACTERAEMIA 2 0.0008
201 FULL BLOOD COUNT INCREASED 1 0.0008
202 PNEUMOCYSTIS JIROVECII INFECTION 1 0.0008
203 ESCHERICHIA TEST POSITIVE 1 0.0008
204 BONE LESION 3 0.0008
205 CLOSTRIDIUM COLITIS 1 0.0008
206 ORAL MUCOSA EROSION 1 0.0008
207 BLAST CRISIS IN MYELOGENOUS LEUKAEMIA 1 0.0008
208 CARDIAC DYSFUNCTION 3 0.0008
209 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 1 0.0008
210 OSTEITIS 2 0.0008
211 KLEBSIELLA INFECTION 4 0.0008
212 TESTICULAR SWELLING 1 0.0008
213 LEFT ATRIAL DILATATION 1 0.0008
214 HEPATIC INFECTION 1 0.0008
215 OBSTRUCTION GASTRIC 1 0.0008
216 DACRYOSTENOSIS ACQUIRED 1 0.0008
217 MESOTHELIOMA 1 0.0008
218 PULMONARY HAEMORRHAGE 6 0.0008
219 PSYCHOMOTOR SKILLS IMPAIRED 2 0.0008
220 PRODUCT USE COMPLAINT 12 0.0008
221 OESOPHAGEAL HAEMORRHAGE 1 0.0008
222 DRUG INTOLERANCE 73 0.0008
223 INTESTINAL DILATATION 1 0.0007
224 SIALOADENITIS 1 0.0007
225 SECOND PRIMARY MALIGNANCY 6 0.0007
226 DIABETIC METABOLIC DECOMPENSATION 1 0.0007
227 CHOLECYSTITIS INFECTIVE 2 0.0007
228 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 1 0.0007
229 NEUTROPENIC SEPSIS 5 0.0007
230 STAPHYLOCOCCAL BACTERAEMIA 3 0.0007
231 MUCOSAL INFLAMMATION 18 0.0007
232 CYTOMEGALOVIRUS INFECTION REACTIVATION 3 0.0007
233 GASTRITIS HAEMORRHAGIC 1 0.0007
234 BONE MARROW DISORDER 2 0.0007
235 DISEASE COMPLICATION 3 0.0007
236 OSTEOSCLEROSIS 1 0.0006
237 ACUTE LEUKAEMIA 1 0.0006
238 HEPATITIS ACUTE 4 0.0006
239 PULMONARY ARTERIAL PRESSURE INCREASED 1 0.0006
240 DECREASED IMMUNE RESPONSIVENESS 6 0.0006
241 DERMATITIS EXFOLIATIVE 3 0.0006
242 ENTEROBACTER INFECTION 1 0.0006
243 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 3 0.0006
244 TONGUE ULCERATION 2 0.0006
245 AGRANULOCYTOSIS 11 0.0006
246 BLOOD CREATININE ABNORMAL 2 0.0006
247 LARGE INTESTINE PERFORATION 4 0.0006
248 SEPTIC SHOCK 25 0.0006
249 APLASTIC ANAEMIA 3 0.0006
250 PSEUDOMONAL SEPSIS 1 0.0006
251 GASTROINTESTINAL OEDEMA 1 0.0006
252 INDURATION 1 0.0006
253 ELECTROCARDIOGRAM QT PROLONGED 20 0.0006
254 OESOPHAGEAL SPASM 1 0.0005
255 HEPATOTOXICITY 12 0.0005
256 PLATELET COUNT DECREASED 57 0.0005
257 NASAL OBSTRUCTION 1 0.0005
258 PERIORBITAL SWELLING 3 0.0005
259 INTERVERTEBRAL DISCITIS 1 0.0005
260 PARANASAL SINUS DISCOMFORT 2 0.0005
261 HEPATIC MASS 1 0.0005
262 PERICARDIAL EFFUSION 12 0.0005
263 MALIGNANT NEOPLASM PROGRESSION 53 0.0005
264 CARDIOPULMONARY FAILURE 2 0.0005
265 CONCOMITANT DISEASE PROGRESSION 1 0.0005
266 MULTI-ORGAN DISORDER 1 0.0005
267 GENE MUTATION 1 0.0005
268 CELL DEATH 1 0.0005
269 BLOOD DISORDER 4 0.0005
270 HEPATITIS CHOLESTATIC 3 0.0005
271 CARDIAC DISCOMFORT 1 0.0005
272 ORGAN FAILURE 2 0.0005
273 SHOCK HAEMORRHAGIC 4 0.0005
274 RECURRENT CANCER 2 0.0005
275 CHOLANGITIS SCLEROSING 1 0.0005
276 ESCHERICHIA INFECTION 4 0.0005
277 MYELODYSPLASTIC SYNDROME 7 0.0005
278 CAPILLARY LEAK SYNDROME 1 0.0005
279 AKINESIA 1 0.0005
280 WHITE BLOOD CELL COUNT ABNORMAL 3 0.0005
281 ENTERITIS 3 0.0005
282 CHOLESTASIS 9 0.0005
283 HYPERPHOSPHATAEMIA 1 0.0005
284 ABSCESS INTESTINAL 1 0.0005
285 PERIODONTITIS 1 0.0005
286 BLOOD COUNT ABNORMAL 7 0.0005
287 ATRIOVENTRICULAR BLOCK FIRST DEGREE 2 0.0005
288 RESPIRATORY SYNCYTIAL VIRUS INFECTION 4 0.0005
289 ELECTROCARDIOGRAM T WAVE INVERSION 1 0.0005
290 BLOOD CREATINE INCREASED 2 0.0005
291 CARDIAC FAILURE ACUTE 3 0.0004
292 BACTERIAL TEST POSITIVE 1 0.0004
293 FULL BLOOD COUNT DECREASED 9 0.0004
294 LARGE INTESTINAL HAEMORRHAGE 1 0.0004
295 COLITIS ISCHAEMIC 3 0.0004
296 BLOOD BILIRUBIN INCREASED 12 0.0004
297 RENAL COLIC 1 0.0004
298 PNEUMONITIS 12 0.0004
299 READING DISORDER 1 0.0004
300 DENGUE FEVER 1 0.0004
301 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 1 0.0004
302 BILIRUBIN CONJUGATED INCREASED 1 0.0004
303 TRANSPLANT 1 0.0004
304 INTRA-ABDOMINAL HAEMORRHAGE 1 0.0004
305 CLOSTRIDIUM DIFFICILE INFECTION 9 0.0004
306 TRANSPLANT FAILURE 1 0.0004
307 TACHYARRHYTHMIA 1 0.0004
308 VENOOCCLUSIVE DISEASE 1 0.0004
309 VENTRICULAR HYPERTROPHY 1 0.0004
310 SYSTEMIC CANDIDA 1 0.0004
311 TOXIC SKIN ERUPTION 4 0.0004
312 TOXIC ENCEPHALOPATHY 2 0.0004
313 MUSCLE ATROPHY 5 0.0004
314 SEPSIS 44 0.0004
315 HAEMODYNAMIC INSTABILITY 3 0.0004
316 APPENDICITIS PERFORATED 1 0.0004
317 VENTRICULAR DYSFUNCTION 1 0.0004
318 PETECHIAE 4 0.0004
319 PRODUCT ODOUR ABNORMAL 4 0.0004
320 DEATH 329 0.0004
321 LUNG OPACITY 1 0.0004
322 ANIMAL BITE 1 0.0004
323 ASCITES 11 0.0004
324 ANAL FISSURE 2 0.0004
325 WEIGHT BEARING DIFFICULTY 1 0.0004
326 ABDOMINAL RIGIDITY 1 0.0004
327 THROMBOCYTOPENIA 41 0.0004
328 GASTROINTESTINAL PAIN 4 0.0004
329 DEAFNESS UNILATERAL 2 0.0004
330 SPINAL COMPRESSION FRACTURE 3 0.0004
331 DRUG LEVEL BELOW THERAPEUTIC 2 0.0004
332 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 1 0.0004
333 LUNG CONSOLIDATION 1 0.0004
334 PROCTITIS 1 0.0004
335 DRUG TOLERANCE DECREASED 1 0.0004
336 HAEMATOLOGICAL MALIGNANCY 1 0.0004
337 GRANULOCYTOPENIA 2 0.0004
338 DRUG-INDUCED LIVER INJURY 11 0.0004
339 BLOOD URIC ACID INCREASED 2 0.0003
340 EYELID MARGIN CRUSTING 1 0.0003
341 COMA SCALE ABNORMAL 1 0.0003
342 ADENOVIRUS INFECTION 1 0.0003
343 STRESS CARDIOMYOPATHY 2 0.0003
344 BILIARY COLIC 1 0.0003
345 PULMONARY PAIN 1 0.0003
346 IMMUNOSUPPRESSION 3 0.0003
347 CREPITATIONS 1 0.0003
348 PULMONARY OEDEMA 15 0.0003
349 BRAIN HERNIATION 1 0.0003
350 LEUKOCYTOSIS 6 0.0003
351 MYELOFIBROSIS 1 0.0003
352 EYE INJURY 1 0.0003
353 KERATITIS 1 0.0003
354 DEVICE RELATED INFECTION 5 0.0003
355 CONCOMITANT DISEASE AGGRAVATED 2 0.0003
356 THERAPY PARTIAL RESPONDER 5 0.0003
357 NEUTROPHIL COUNT DECREASED 13 0.0003
358 COLITIS 12 0.0003
359 IRIDOCYCLITIS 1 0.0003
360 NEOPLASM PROGRESSION 11 0.0003
361 ORTHOPNOEA 1 0.0003
362 SUPRAVENTRICULAR TACHYCARDIA 3 0.0003
363 VENTRICULAR HYPOKINESIA 1 0.0003
364 ANTINUCLEAR ANTIBODY POSITIVE 1 0.0003
365 POSTURE ABNORMAL 1 0.0003
366 LISTLESS 1 0.0003
367 SUSPECTED COVID-19 1 0.0003
368 NEAR DEATH EXPERIENCE 1 0.0003
369 PNEUMOCYSTIS JIROVECII PNEUMONIA 3 0.0003
370 CEREBRAL HAEMATOMA 1 0.0003
371 JAUNDICE 8 0.0003
372 CANDIDA INFECTION 5 0.0003
373 HEPATIC CYST 1 0.0003
374 HOSPITALISATION 45 0.0003
375 THERAPY CESSATION 15 0.0003
376 APLASIA PURE RED CELL 1 0.0003
377 ONYCHOCLASIS 2 0.0003
378 LEFT VENTRICULAR FAILURE 1 0.0003
379 ENCEPHALITIS 2 0.0003
380 TRANSFUSION 3 0.0003
381 DYSPHAGIA 27 0.0003
382 BRONCHIOLITIS 1 0.0003
383 FULL BLOOD COUNT ABNORMAL 3 0.0003
384 INFECTION 41 0.0003
385 GLOSSITIS 1 0.0003
386 LIVER FUNCTION TEST INCREASED 6 0.0003
387 SCLERODERMA 1 0.0003
388 C-REACTIVE PROTEIN INCREASED 10 0.0003
389 OESOPHAGITIS 3 0.0003
390 CARDIAC FAILURE 22 0.0003
391 RECTAL DISCHARGE 1 0.0003
392 GAMMA-GLUTAMYLTRANSFERASE INCREASED 6 0.0003
393 LOWER GASTROINTESTINAL HAEMORRHAGE 2 0.0003
394 RASH MACULO-PAPULAR 6 0.0003
395 LEUKOENCEPHALOPATHY 1 0.0003
396 PROTEIN TOTAL DECREASED 1 0.0003
397 PYREXIA 91 0.0003
398 PLEURAL EFFUSION 16 0.0003
399 TROPONIN INCREASED 2 0.0003
400 PROCEDURAL COMPLICATION 2 0.0003
401 DIFFUSE LARGE B-CELL LYMPHOMA 2 0.0003
402 THERAPEUTIC PRODUCT INEFFECTIVE 1 0.0003
403 EYELID OEDEMA 3 0.0003
404 HYPOALBUMINAEMIA 2 0.0003
405 SPLENOMEGALY 3 0.0003
406 BONE PAIN 15 0.0003
407 EPIGASTRIC DISCOMFORT 1 0.0003
408 VENOUS THROMBOSIS 1 0.0003
409 SKIN ODOUR ABNORMAL 1 0.0003
410 RESPIRATORY DISTRESS 7 0.0003
411 BLOOD ALBUMIN DECREASED 2 0.0003
412 CREATININE RENAL CLEARANCE DECREASED 1 0.0002
413 PERIPHERAL ISCHAEMIA 1 0.0002
414 DEMYELINATION 1 0.0002
415 NEUTROPENIA 33 0.0002
416 STAPHYLOCOCCAL INFECTION 8 0.0002
417 GENERALISED OEDEMA 3 0.0002
418 ILEUS 3 0.0002
419 CONGESTIVE CARDIOMYOPATHY 1 0.0002
420 PERICARDITIS 4 0.0002
421 HYPERPYREXIA 1 0.0002
422 MUSCLE FATIGUE 1 0.0002
423 LEFT VENTRICULAR HYPERTROPHY 1 0.0002
424 PSEUDOMONAS INFECTION 2 0.0002
425 RESPIRATORY FAILURE 17 0.0002
426 METASTASES TO CENTRAL NERVOUS SYSTEM 3 0.0002
427 ANURIA 2 0.0002
428 TUMOUR LYSIS SYNDROME 2 0.0002
429 HYPOXIA 8 0.0002
430 ILEUS PARALYTIC 1 0.0002
431 VOMITING 105 0.0002
432 WHITE BLOOD CELL COUNT DECREASED 24 0.0002
433 BLOOD THYROID STIMULATING HORMONE DECREASED 1 0.0002
434 HAEMOGLOBIN INCREASED 1 0.0002
435 LUMBAR VERTEBRAL FRACTURE 1 0.0002
436 LOCALISED OEDEMA 1 0.0002
437 PERFORMANCE STATUS DECREASED 1 0.0002
438 MULTIPLE ORGAN DYSFUNCTION SYNDROME 6 0.0002
439 THERAPY INTERRUPTED 15 0.0002
440 NAUSEA 166 0.0002
441 HYPOACUSIS 9 0.0002
442 GASTROINTESTINAL TOXICITY 1 0.0002
443 GUILLAIN-BARRE SYNDROME 1 0.0002
444 HAEMATURIA 7 0.0002
445 CARDIOMYOPATHY 3 0.0002
446 LIGAMENT SPRAIN 2 0.0002
447 ORGANISING PNEUMONIA 1 0.0002
448 INFLAMMATORY MARKER INCREASED 1 0.0002
449 SALIVARY HYPERSECRETION 2 0.0002
450 FEEDING DISORDER 4 0.0002
451 BODY TEMPERATURE INCREASED 4 0.0002
452 AMMONIA INCREASED 1 0.0002
453 ENDOCARDITIS 1 0.0002
454 PRODUCT TEMPERATURE EXCURSION ISSUE 1 0.0002
455 PERIORBITAL OEDEMA 1 0.0002
456 MALABSORPTION 1 0.0002
457 CYANOSIS 3 0.0002
458 FOLLICULITIS 2 0.0002
459 NYSTAGMUS 1 0.0002
460 ASPARTATE AMINOTRANSFERASE INCREASED 10 0.0002
461 ASPIRATION 2 0.0002
462 NONSPECIFIC REACTION 1 0.0002
463 MELAENA 4 0.0002
464 INTESTINAL ISCHAEMIA 1 0.0002
465 THERAPEUTIC RESPONSE DECREASED 11 0.0002
466 TRANSAMINASES INCREASED 4 0.0002
467 URINARY RETENTION 6 0.0002
468 STREPTOCOCCAL INFECTION 1 0.0002
469 CELLULITIS 9 0.0002
470 MACULAR OEDEMA 1 0.0002
471 INTESTINAL PERFORATION 2 0.0002
472 DISEASE PROGRESSION 21 0.0002
473 MITRAL VALVE INCOMPETENCE 2 0.0002
474 HEPATIC ENZYME INCREASED 12 0.0002
475 PERONEAL NERVE PALSY 1 0.0002
476 NEUTROPHILIA 1 0.0002
477 MYOCARDIAL ISCHAEMIA 2 0.0002
478 HAEMOGLOBIN DECREASED 18 0.0002
479 ILLNESS 18 0.0002
480 PRODUCT LABEL CONFUSION 1 0.0002
481 HEAD DISCOMFORT 3 0.0002
482 LABORATORY TEST ABNORMAL 5 0.0002
483 COVID-19 PNEUMONIA 2 0.0002
484 ATAXIA 2 0.0002
485 GALLBLADDER DISORDER 3 0.0002
486 CHOLECYSTITIS 2 0.0002
487 CEREBRAL HAEMORRHAGE 6 0.0002
488 MACULAR DEGENERATION 2 0.0002
489 PROTHROMBIN TIME PROLONGED 1 0.0002
490 TYPE 1 DIABETES MELLITUS 1 0.0002
491 GANGRENE 1 0.0002
492 HEPATIC FAILURE 5 0.0002
493 SQUAMOUS CELL CARCINOMA OF SKIN 1 0.0002
494 PLATELET COUNT ABNORMAL 1 0.0002
495 INTERSTITIAL LUNG DISEASE 8 0.0002
496 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0002
497 PNEUMONIA 53 0.0002
498 ANAEMIA 31 0.0002
499 OLIGURIA 1 0.0002
500 HAIR COLOUR CHANGES 2 0.0002
501 AGEUSIA 4 0.0002
502 NASAL DRYNESS 1 0.0002
503 HERPES SIMPLEX 1 0.0002
504 CHOKING 3 0.0002
505 PLATELET COUNT INCREASED 2 0.0002
506 CHOLELITHIASIS 5 0.0002
507 IMPAIRED HEALING 5 0.0002
508 DYSGRAPHIA 1 0.0002
509 PULMONARY CONGESTION 2 0.0002
510 APPETITE DISORDER 1 0.0002
511 FUNGAL INFECTION 5 0.0001
512 NEOPLASM MALIGNANT 10 0.0001
513 SKIN MASS 1 0.0001
514 MENINGITIS 1 0.0001
515 GAIT INABILITY 5 0.0001
516 LEFT VENTRICULAR DYSFUNCTION 1 0.0001
517 OEDEMA 8 0.0001
518 GENERAL PHYSICAL CONDITION ABNORMAL 1 0.0001
519 ALANINE AMINOTRANSFERASE INCREASED 9 0.0001
520 TACHYCARDIA 13 0.0001
521 ECCHYMOSIS 1 0.0001
522 JOINT EFFUSION 1 0.0001
523 DROOLING 1 0.0001
524 HYPERTRANSAMINASAEMIA 1 0.0001
525 GASTROINTESTINAL HAEMORRHAGE 12 0.0001
526 LUNG DISORDER 7 0.0001
527 PULMONARY TOXICITY 1 0.0001
528 PRODUCT SUPPLY ISSUE 1 0.0001
529 LEUKOPENIA 7 0.0001
530 RED BLOOD CELL COUNT DECREASED 4 0.0001
531 DIARRHOEA 90 0.0001
532 RASH PUSTULAR 1 0.0001
533 HYPERGLYCAEMIA 5 0.0001
534 COVID-19 24 0.0001
535 ORAL DISORDER 1 0.0001
536 MOUTH HAEMORRHAGE 1 0.0001
537 SENSITIVE SKIN 1 0.0001
538 HYPOPHOSPHATAEMIA 1 0.0001
539 LIVER DISORDER 6 0.0001
540 ARTHROPOD BITE 1 0.0001
541 EYE SWELLING 5 0.0001
542 GASTROINTESTINAL DISORDER 12 0.0001
543 RASH PAPULAR 3 0.0001
544 DYSARTHRIA 5 0.0001
545 CONTRAINDICATED PRODUCT ADMINISTERED 4 0.0001
546 STOMATITIS 8 0.0001
547 TOXIC EPIDERMAL NECROLYSIS 2 0.0001
548 INSURANCE ISSUE 2 0.0001
549 WHITE BLOOD CELL COUNT INCREASED 5 0.0001
550 PHARYNGEAL OEDEMA 2 0.0001
551 THYROID DISORDER 2 0.0001
552 GENERAL PHYSICAL HEALTH DETERIORATION 15 0.0001
553 HAEMORRHAGIC STROKE 1 0.0001
554 ELECTROCARDIOGRAM ABNORMAL 1 0.0001
555 NASAL DISCOMFORT 1 0.0001
556 DISEASE RECURRENCE 6 0.0001
557 TRICUSPID VALVE INCOMPETENCE 1 0.0001
558 NIGHT SWEATS 4 0.0001
559 ATRIAL FIBRILLATION 12 0.0001
560 ENCEPHALOPATHY 3 0.0001
561 POLYURIA 1 0.0001
562 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 1 0.0001
563 PHOTOSENSITIVITY REACTION 2 0.0001
564 BLOOD ALKALINE PHOSPHATASE INCREASED 3 0.0001
565 COAGULOPATHY 2 0.0001
566 DRUG INTERACTION 19 0.0001
567 CARDIO-RESPIRATORY ARREST 5 0.0001
568 BLOOD UREA INCREASED 2 0.0001
569 FACE OEDEMA 2 0.0001
570 HYPOPHAGIA 3 0.0001
571 FACIAL PARALYSIS 1 0.0001
572 ABDOMINAL PAIN 27 0.0001
573 MUSCLE STRAIN 1 0.0001
574 PYELONEPHRITIS 1 0.0001
575 BLOOD TRIGLYCERIDES INCREASED 2 0.0001
576 LYMPHOCYTE COUNT DECREASED 2 0.0001
577 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 1 0.0001
578 ACUTE RESPIRATORY DISTRESS SYNDROME 2 0.0001
579 PURPURA 1 0.0001
580 RESPIRATORY RATE INCREASED 1 0.0001
581 CARDIOTOXICITY 1 0.0001
582 THERAPY NON-RESPONDER 5 0.0001
583 ANAL INCONTINENCE 1 0.0001
584 PATHOGEN RESISTANCE 1 0.0001
585 SKIN LESION 3 0.0001
586 BRAIN NEOPLASM 1 0.0001
587 NERVE COMPRESSION 1 0.0001
588 PRODUCT DISTRIBUTION ISSUE 1 0.0001
589 ABDOMINAL DISCOMFORT 18 0.0001
590 BACTERIAL INFECTION 2 0.0001
591 NEPHROPATHY 1 0.0001
592 SWELLING 10 0.0001
593 LACERATION 1 0.0001
594 SQUAMOUS CELL CARCINOMA 1 0.0001
595 ARRHYTHMIA 5 0.0001
596 HAEMATOTOXICITY 1 0.0001
597 GASTRIC ULCER 2 0.0001
598 PROTEINURIA 2 0.0001
599 MALAISE 46 0.0001
600 EAR PAIN 2 0.0001
601 HAEMORRHOIDS 2 0.0001
602 PLASMA CELL MYELOMA 4 0.0001
603 ORAL HERPES 2 0.0001
604 PHARYNGEAL SWELLING 1 0.0001
605 BODY TEMPERATURE DECREASED 1 0.0001
606 BLOOD PRESSURE ABNORMAL 2 0.0001
607 RESPIRATORY DISORDER 3 0.0001
608 OVARIAN CYST 1 0.0001
609 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 18 0.0001
610 CYTOKINE RELEASE SYNDROME 2 0.0001
611 EMPHYSEMA 1 0.0001
612 TOOTH ABSCESS 1 0.0001
613 BLINDNESS 4 0.0001
614 ACUTE KIDNEY INJURY 15 0.0001
615 CARDIAC ARREST 8 0.0001
616 PERITONITIS 2 0.0001
617 VENTRICULAR EXTRASYSTOLES 1 0.0001
618 HALLUCINATION, VISUAL 2 0.0001
619 DECREASED APPETITE 22 0.0001
620 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
621 BRADYCARDIA 5 0.0001
622 RETCHING 2 0.0001
623 SWELLING FACE 6 0.0001
624 SKIN LACERATION 1 0.0001
625 BACK INJURY 1 0.0001
626 DENTAL CARIES 1 0.0001
627 RENAL FAILURE 12 0.0001
628 OBSTRUCTIVE AIRWAYS DISORDER 1 0.0001
629 MALNUTRITION 1 0.0001
630 SKIN INFECTION 1 0.0001
631 OCULAR DISCOMFORT 1 0.0001
632 HEART RATE IRREGULAR 2 0.0001
633 REBOUND EFFECT 1 0.0001
634 PRODUCT AVAILABILITY ISSUE 2 0.0001
635 CHOLECYSTECTOMY 1 0.0001
636 GASTRIC DISORDER 3 0.0001
637 GASTRIC HAEMORRHAGE 1 0.0001
638 UPPER RESPIRATORY TRACT INFECTION 4 0.0001
639 ABDOMINAL DISTENSION 9 0.0001
640 RENAL DISORDER 4 0.0001
641 RASH MACULAR 3 0.0001
642 CARDIAC DISORDER 8 0.0001
643 NASAL CONGESTION 5 0.0001
644 TREATMENT FAILURE 7 0.0001
645 RASH ERYTHEMATOUS 4 0.0001
646 CONTUSION 8 0.0001
647 ADRENAL INSUFFICIENCY 1 0.0001
648 ILL-DEFINED DISORDER 5 0.0001
649 PRESYNCOPE 2 0.0001
650 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
651 CARDIOMEGALY 1 0.0001
652 SMALL INTESTINAL OBSTRUCTION 1 0.0001
653 TENDON RUPTURE 1 0.0001
654 HEPATIC FUNCTION ABNORMAL 3 0.0001
655 RASH 35 0.0001
656 EPISTAXIS 6 0.0001
657 BRAIN OEDEMA 1 0.0001
658 HAEMATEMESIS 2 0.0001
659 DIABETES MELLITUS 6 0.0001
660 MYDRIASIS 1 0.0001
661 UNRESPONSIVE TO STIMULI 2 0.0001
662 RASH GENERALISED 2 0.0001
663 HAEMATOMA 2 0.0001
664 AMNESIA 5 0.0001
665 NODULE 1 0.0001
666 JOINT STIFFNESS 2 0.0001
667 DRUG INEFFECTIVE 100 0.0001
668 TOOTH INFECTION 1 0.0001
669 SARS-COV-2 TEST POSITIVE 1 0.0001
670 EYE HAEMORRHAGE 1 0.0001
671 GASTROOESOPHAGEAL REFLUX DISEASE 6 0.0001
672 PRODUCT USE ISSUE 14 0.0001
673 ASTHENIA 28 0.0001
674 OEDEMA PERIPHERAL 9 0.0001
675 TACHYPNOEA 1 0.0001
676 IMPAIRED GASTRIC EMPTYING 1 0.0001
677 GINGIVAL BLEEDING 1 0.0001
678 PRODUCT USE IN UNAPPROVED INDICATION 18 0.0001
679 ANAPHYLACTIC REACTION 4 0.0001
680 DIVERTICULITIS 2 0.0001
681 HYPOMAGNESAEMIA 1 0.0001
682 HAEMOPTYSIS 2 0.0001
683 APHONIA 1 0.0001
684 CARPAL TUNNEL SYNDROME 1 0.0001
685 PERIPHERAL SWELLING 11 0.0001
686 BLOOD TEST ABNORMAL 1 0.0001
687 BLINDNESS UNILATERAL 1 0.0001
688 PRODUCT DOSE OMISSION IN ERROR 2 0.0001
689 HEPATOCELLULAR INJURY 1 0.0001
690 SINUS TACHYCARDIA 1 0.0001
691 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 5 0.0001
692 BRONCHOSPASM 1 0.0001
693 PARALYSIS 1 0.0001
694 HYPERSOMNIA 2 0.0001
695 CARDIOGENIC SHOCK 1 0.0001
696 ANOSMIA 1 0.0001
697 HYPERTHYROIDISM 1 0.0001
698 CONSTIPATION 15 0.0001
699 FLUID OVERLOAD 1 0.0001
700 DYSSTASIA 2 0.0001
701 PULMONARY MASS 1 0.0001
702 IMMUNODEFICIENCY 1 0.0001
703 HYPOAESTHESIA ORAL 1 0.0001
704 APHASIA 2 0.0001
705 CORONARY ARTERY DISEASE 2 0.0001
706 LOWER RESPIRATORY TRACT INFECTION 3 0.0001
707 VERTIGO 4 0.0001
708 EPILEPSY 2 0.0001
709 NEPHROLITHIASIS 3 0.0001
710 SKIN DISCOLOURATION 3 0.0001
711 HYPOKALAEMIA 3 0.0001
712 CHEST PAIN 12 0.0001
713 LIMB DISCOMFORT 2 0.0001
714 LUNG INFECTION 1 0.0001
715 BASAL CELL CARCINOMA 1 0.0001
716 HEAD INJURY 2 0.0001
717 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
718 PNEUMOTHORAX 1 0.0001
719 OBESITY 1 0.0001
720 DEEP VEIN THROMBOSIS 4 0.0001
721 BLOOD CREATININE INCREASED 4 0.0001
722 NO ADVERSE EVENT 11 0.0001
723 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
724 DRUG LEVEL INCREASED 1 0.0001
725 LIP SWELLING 2 0.0001
726 SKIN DISORDER 2 0.0001
727 CHILLS 7 0.0001
728 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
729 FLUID RETENTION 3 0.0001
730 CIRCULATORY COLLAPSE 1 0.0001
731 URINARY TRACT INFECTION 10 0.0001
732 SINUSITIS 6 0.0001
733 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
734 ABDOMINAL PAIN UPPER 12 0.0001
735 MUSCULOSKELETAL DISCOMFORT 1 0.0001
736 WEIGHT INCREASED 13 0.0001
737 JOINT SWELLING 7 0.0001
738 EOSINOPHILIA 1 0.0001
739 DRUG ERUPTION 1 0.0001
740 PELVIC PAIN 1 0.0001
741 PANIC ATTACK 2 0.0001
742 HYPOTENSION 11 0.0001
743 HAEMATOCHEZIA 3 0.0001
744 DYSURIA 2 0.0001
745 BLOOD GLUCOSE ABNORMAL 1 0.0001
746 OROPHARYNGEAL PAIN 5 0.0001
747 DYSGEUSIA 4 0.0001
748 THINKING ABNORMAL 1 0.0001
749 OXYGEN SATURATION DECREASED 3 0.0001
750 HYPOCALCAEMIA 1 0.0001
751 PULMONARY FIBROSIS 1 0.0001
752 POST PROCEDURAL COMPLICATION 1 0.0001
753 LOWER LIMB FRACTURE 1 0.0001
754 ACUTE RESPIRATORY FAILURE 1 0.0001
755 HERNIA 1 0.0001
756 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
757 KIDNEY INFECTION 1 0.0001
758 DEPRESSED LEVEL OF CONSCIOUSNESS 2 0.0001
759 HEART RATE INCREASED 5 0.0001
760 HAEMATOCRIT DECREASED 1 0.0001
761 PRESCRIBED UNDERDOSE 1 0.0001
762 FATIGUE 39 0.0001
763 CARDIAC FAILURE CONGESTIVE 4 0.0000
764 PRODUCT PHYSICAL ISSUE 1 0.0000
765 DYSPNOEA 28 0.0000
766 FLUSHING 5 0.0000
767 OFF LABEL USE 43 0.0000
768 CHEST DISCOMFORT 5 0.0000
769 TREMOR 8 0.0000
770 PULMONARY HYPERTENSION 1 0.0000
771 DERMATITIS 1 0.0000
772 HYPERTENSION 10 0.0000
773 HYPERHIDROSIS 6 0.0000
774 RECTAL HAEMORRHAGE 2 0.0000
775 POOR QUALITY SLEEP 1 0.0000
776 CONDITION AGGRAVATED 14 0.0000
777 PRODUCT DISPENSING ERROR 1 0.0000
778 FEELING ABNORMAL 11 0.0000
779 ANGIOEDEMA 2 0.0000
780 COLITIS ULCERATIVE 2 0.0000
781 ORAL PAIN 1 0.0000
782 HEADACHE 28 0.0000
783 PANCREATITIS ACUTE 1 0.0000
784 CHROMATURIA 1 0.0000
785 MEMORY IMPAIRMENT 6 0.0000
786 MUSCLE SPASMS 8 0.0000
787 TINNITUS 2 0.0000
788 SHOCK 1 0.0000
789 SEIZURE 5 0.0000
790 WEIGHT DECREASED 12 0.0000
791 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1 0.0000
792 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3 0.0000
793 PULMONARY EMBOLISM 4 0.0000
794 COMA 2 0.0000
795 PRODUCTIVE COUGH 2 0.0000
796 INSOMNIA 11 0.0000
797 PRODUCT DOSE OMISSION ISSUE 12 0.0000
798 DIZZINESS 20 0.0000
799 DRY EYE 2 0.0000
800 AGGRESSION 2 0.0000
801 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
802 CARDIOVASCULAR DISORDER 1 0.0000
803 ERYTHEMA 8 0.0000
804 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1 0.0000
805 SPEECH DISORDER 2 0.0000
806 GASTRITIS 1 0.0000
807 PANCREATITIS 2 0.0000
808 DEPRESSED MOOD 2 0.0000
809 THROMBOSIS 3 0.0000
810 PAIN OF SKIN 1 0.0000
811 DISTURBANCE IN ATTENTION 2 0.0000
812 THROAT TIGHTNESS 1 0.0000
813 LIMB INJURY 1 0.0000
814 MOOD ALTERED 1 0.0000
815 RESPIRATORY ARREST 1 0.0000
816 MENTAL STATUS CHANGES 1 0.0000
817 URTICARIA 6 0.0000
818 DEMENTIA 1 0.0000
819 WOUND 1 0.0000
820 RENAL IMPAIRMENT 3 0.0000
821 COUGH 10 0.0000
822 EYE PAIN 2 0.0000
823 CEREBROVASCULAR ACCIDENT 6 0.0000
824 PAIN IN JAW 1 0.0000
825 MYALGIA 6 0.0000
826 MUSCULAR WEAKNESS 4 0.0000
827 INTENTIONAL DOSE OMISSION 1 0.0000
828 INCORRECT DOSE ADMINISTERED 8 0.0000
829 ANGINA PECTORIS 1 0.0000
830 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
831 PANCREATIC CARCINOMA 1 0.0000
832 BACK PAIN 8 0.0000
833 MYOCARDIAL INFARCTION 6 0.0000
834 PRODUCT STORAGE ERROR 3 0.0000
835 SURGERY 2 0.0000
836 PSYCHOTIC DISORDER 1 0.0000
837 URINARY INCONTINENCE 1 0.0000
838 NASOPHARYNGITIS 6 0.0000
839 NERVOUS SYSTEM DISORDER 1 0.0000
840 SWOLLEN TONGUE 1 0.0000
841 LOSS OF CONSCIOUSNESS 4 0.0000
842 MOVEMENT DISORDER 1 0.0000
843 CONFUSIONAL STATE 5 0.0000
844 LACTIC ACIDOSIS 1 0.0000
845 PRODUCT DOSE OMISSION 2 0.0000
846 DYSPEPSIA 3 0.0000
847 BLOOD PRESSURE DECREASED 2 0.0000
848 VIRAL INFECTION 1 0.0000
849 SYNCOPE 3 0.0000
850 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 6 0.0000
851 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
852 MULTIPLE SCLEROSIS RELAPSE 2 0.0000
853 MOBILITY DECREASED 2 0.0000
854 OVERDOSE 6 0.0000
855 PAIN 17 0.0000
856 DRUG EFFECT INCOMPLETE 1 0.0000
857 UNDERDOSE 2 0.0000
858 RESTLESSNESS 1 0.0000
859 BRONCHITIS 2 0.0000
860 HYPOAESTHESIA 4 0.0000
861 PRURITUS 10 0.0000
862 ALOPECIA 5 0.0000
863 PARAESTHESIA 4 0.0000
864 DISORIENTATION 1 0.0000
865 DYSKINESIA 1 0.0000
866 OSTEOPOROSIS 1 0.0000
867 FALL 8 0.0000
868 POLLAKIURIA 1 0.0000
869 TOXICITY TO VARIOUS AGENTS 4 0.0000
870 MENTAL DISORDER 1 0.0000
871 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
872 DEHYDRATION 3 0.0000
873 THROAT IRRITATION 1 0.0000
874 ADVERSE DRUG REACTION 2 0.0000
875 VISION BLURRED 3 0.0000
876 ADVERSE EVENT 2 0.0000
877 BLOOD CHOLESTEROL INCREASED 1 0.0000
878 OCULAR HYPERAEMIA 1 0.0000
879 RENAL CANCER 1 0.0000
880 MIGRAINE 2 0.0000
881 BLOOD PRESSURE INCREASED 3 0.0000
882 INFLAMMATION 1 0.0000
883 ARTHRALGIA 8 0.0000
884 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
885 NERVOUSNESS 1 0.0000
886 MUSCULOSKELETAL PAIN 1 0.0000
887 RASH PRURITIC 1 0.0000
888 INFLUENZA 2 0.0000
889 BLISTER 1 0.0000
890 HYPONATRAEMIA 1 0.0000
891 HERPES ZOSTER 1 0.0000
892 DYSPHONIA 1 0.0000
893 PALPITATIONS 2 0.0000
894 PAIN IN EXTREMITY 5 0.0000
895 IRRITABILITY 1 0.0000
896 SUICIDE ATTEMPT 1 0.0000
897 HYPERSENSITIVITY 3 0.0000
898 VISUAL IMPAIRMENT 2 0.0000
899 BURNING SENSATION 1 0.0000
900 INJURY 1 0.0000
901 SKIN BURNING SENSATION 1 0.0000
902 UNEVALUABLE EVENT 1 0.0000
903 ARTHRITIS 1 0.0000
904 INFLUENZA LIKE ILLNESS 1 0.0000
905 MUSCULOSKELETAL STIFFNESS 1 0.0000
906 ANXIETY 3 0.0000
907 NEUROPATHY PERIPHERAL 1 0.0000
908 DEPRESSION 2 0.0000
909 DRY SKIN 1 0.0000
910 SOMNOLENCE 1 0.0000